1. DSpace at My University
  2. E-Journal
  3. Keperawatan
  4. Jurnal Internasional
  5. 2. Australian Journal of Advanced Nursing
Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1294
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMatilda Schmidt, Amy Arnold-
dc.contributor.authorJulia Brownlie-
dc.date.accessioned2022-06-23T02:19:34Z-
dc.date.available2022-06-23T02:19:34Z-
dc.date.issued2022-02-28-
dc.identifier.citationVol. 39 No. 1 (2022): Desember - Februari 2022en_US
dc.identifier.issn1447‑4328-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1294-
dc.descriptionA total of 228 patients received anti-D Ig, with the majority being less than twelve weeks in gestation (169, 74.1%). Anti-D Ig was administered without support from the guidelines in 81 (35.5%) patients, with a lack of documented sensitising event in 77 (95%) of these cases.en_US
dc.description.abstractThe objective of this study was to audit the use of anti-D immunoglobulin (anti-D) against the current Australian guidelines in one large inner-city referral hospital over three years and critique the practice identified.en_US
dc.language.isoenen_US
dc.publisherAustralian Nursing & Midwifery Federationen_US
dc.subjectanti-D immunoglobulinen_US
dc.subjectRh(D) alloimmunisationen_US
dc.titleEmergency Clinicians interpretation and application of Anti-D guidelinesen_US
dc.typeArticleen_US
Appears in Collections:2. Australian Journal of Advanced Nursing

Files in This Item:
File Description SizeFormat 
2-6.pdf108.6 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.